JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B1609 Aclidinium Bromide

Summary: LAMAs antagonist

≥28.23 mg/mL
B2174 GSK2334470

Summary: PDK1 inhibitor,highly specific and potent

≥46.3 mg/mL
B1263 CBB1007

Summary: LSD1 inhibitor,potent and selective

Soluble in DMSO
B1070 AHU-377(Sacubitril)

1 Citation

Target: neprilysin

Summary: Neprilysin inhibitor

≥41.1 mg/mL
B2171 Imatinib (STI571)

6 Citation

Target: PDGFR|c-Kit|Bcr-Abl

Summary: Protein-tyrosine kinase inhibitor

≥24.68 mg/mL
B1306 KN-93 hydrochloride

Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)

Summary: CaMK II inhibitor

≥26.9 mg/mL
B1021 EI1

Summary: EZH2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.5 mg/mL
B2228 PF-4708671

1 Citation

Target: p70 rsk

Summary: P70 S6K1 isoform inhibitor,cell-permeable

≥37.8 mg/mL
B1106 Ulixertinib

Target: ERK

Summary: ERK1/ERK2 inhibitor

≥43.3 mg/mL
B1474 FT-207 (NSC 148958)

Summary: DNA/RNA synthesis inhibitor

≥100 mg/mL